TCL Archive In Brief: Congress Asked To Investigate Dieldrin Danger; Harvard’s Rosenberg To Be NCI Surgery Chief April 5, 1974
TCL Archive Merck Serono Cancels Tecemotide Program In NSCLC, Including Two Phase III Trials September 26, 2014
TCL Archive ACC Will Develop Standards, Patient Management Guidelines To Upgrade Community Cancer Programs March 23, 1984